ReviewFolia microbiologica2026
Microbial biobanking: safeguarding the tiny treasures for sustainable human welfare.
Review in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microbial biodiversity is essential for the proper functioning and balance in the ecosystem, and they possess numerous biotechnological and industrial applications. Microbial biobanks serve as a major resource for conserving valuable microbial diversity, providing access for education, research, and industrial applications. The present comprehensive review article discusses the history, responsibilities, and applications of microbial biobanks, covering different regulatory ecosystem and their guidelines for the governance of biobanks. It specifically provides the current global status of MCCs and precisely sheds light on MCCs in India. This review critically highlights a stark disparity in the bio-resources management, showing dominance of Asia with substantial investment in bio-infrastructure. In India, a significant geographical disparity was observed with a heavy concentration of culture collections in states with established research infrastructure. Despite the immense commercial potential of microbes, very few MCCs are held by the private sector globally, leaving the burden of conservation on the public sector and raising concerns about long-term survival and financial instability. Furthermore, there is a critical need for emerging advanced preservation strategies, AI-assisted tools for biobanking operations, and stringent quality control procedures in biobanks meeting international standards. In addition, the findings underscore the necessity of the digitalization of culture collections to facilitate global data sharing and robust policies for access and benefit sharing of microbial resources. In conclusion, addressing these regional disparities, mitigating financial and infrastructure gaps, using emerging and advanced strategies, and digitalization of CCs are imperative for the sustainability and applicability of the microbial biobanks.
Indexed as
Identifiers
42283968What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.